A significant advancement in medical science:
Researchers at Nara Medical University have successfully developed Deoxy-HbV (Deoxygenated Hemoglobin Vesicles). This synthetic blood substitute is designed to replicate the vital function of red blood cells, ensuring oxygen transportation throughout the body.**
6 Likes
Informative synthetic haemoglobin vesicle acts as like red blood cells by transporting oxygen throughout the body also help to collect the carbon dioxide from cells
1 Like
Very Informative.
1 Like
Yes, it’s compatible with all blood type and storable for extended periods.
1 Like
The development of Deoxy-HbV, a synthetic blood substitute by Nara Medical University, is a major step in emergency and trauma care. Unlike traditional blood transfusions, this hemoglobin-based substitute doesn’t require blood typing and has a longer shelf life, making it incredibly useful in disaster zones or rural areas with limited access to donor blood.
If proven safe and scalable, this could bridge a critical gap in healthcare where immediate blood supply is unavailable. It’s fascinating to see how synthetic biology continues to reshape modern medicine.
1 Like
informative.
1 Like
Informative.
1 Like
This is a huge step forward in synthetic biology and transfusion medicine and it will be watching closely as it moves through trials and further testing.
1 Like
Hb-vesicles (HbV). A new encapsulation method using a rotation-revolution mixer which enabled efficient production of HbV with a high yield.Hb-vesicles (HbV).
This innovative technology is gaining attention as a next-gen artificial oxygen carrier—one that’s redefining how we think about transfusions and therapeutic oxygen delivery.
1 Like
A blood substitute like Deoxy-HbV can save lives in emergencies, especially where real blood isn’t available.
1 Like